Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure.

"Disclosures Dr Asselbergs is supported by University College London Hospitals NIH and Care Research Biomedical Research Center. Dr Orsel is an employee of Philips Healthcare. Dr Pinto serves as a consultant and speaker for biotechnology and pharmaceutical companies that develop molecules that target myocardial disease, including Pfizer, Roche, Novartis, and Forbion. Dr Pinto is named inventor on patents related to cardiomyopathy therapy and holds minor shares (<5%) and spin-off aimed at developing therapies for heart disease. All other authors have nothing to disclose."

"Sources of Funding This work was supported within the framework of the Center for Translational Molecular Medicine, project TRIUMPH (grant 01C-103)."

"Registration:: URL: https://www.trialregister.nl/trial/1783; Unique Identifier: NTR1893. (The trial can be found temporarily at https://trialsearch.who.int/Trial2.aspx?TrialID=NTR1893.)"